DIRECTOR DEALINGS: Integrated Diagnostics CEO buys USD3 million worth

(Alliance News) - The following is a round-up of share dealings by London-listed company ...

Alliance News 5 August, 2022 | 1:27PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:

----------

Integrated Diagnostics Holdings PLC - consumer healthcare firm with operations in Egypt, Jordan, Sudan, and Nigeria - Chief Executive Officer Hend El Sherbini buys 3.6 million shares via Hena Holdings Ltd at USD0.90, worth USD3.2 million, on Wednesday.

----------

Pantheon International PLC - investment trust focused on private equity - Non-Executive Director John Burgess buys 758,281 shares via November 1990 Trust at GBP2.64, worth GBP2.0 million, on Thursday.

----------

Bridgepoint Group PLC - private equity investor - Managing Partner Jonathan Hughes buys 200,000 at GBP2.50 and GBP2.52, worth GBP502,185, on Tuesday and Wednesday.

----------

Synthomer PLC - Essex-based chemicals maker - CEO Michael Willome buys 70,000 shares at GBP1.89, worth GBP132,476, on Thursday. Non-Executive Director Alexander Catto buys 50,000 shares at GBP2.01, worth GBP100,376, on Wednesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Pantheon International Ord 325.81 GBX -0.36
Integrated Diagnostics Holdings PLC 0.35 USD 0.00 -
Bridgepoint Group PLC When Issue 224.80 GBX -0.88 -
Synthomer PLC 237.50 GBX -1.66 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures